Press Releases

Press Releases

July 27, 2020
Company’s ultra-sensitive Simoa® technology powers more than 50 posters and presentations on display during this year’s virtual program; attendees can be among the first to experience Simoa p-tau181 assay for improved study of Alzheimer’s disease and visit virtual exhibitor booth
July 20, 2020
Findings from newly published research demonstrate promise of ultra-sensitive biomarker technology to identify and define high-risk populations through quantification of interferon (IFN) type I
June 11, 2020
BILLERICA, Mass.--(BUSINESS WIRE)--

This website uses cookies. By continuing to use this website you are acknowledging and agree with our cookie policy.

AgreeLearn more